Bleeding in the gastrointestinal (“GI”) tract may be associated with various ulcers, lesions, cancers and the like. For example, peptic ulcers in the upper GI tract have been identified as a common cause of GI bleeding. If left untreated, GI bleeding may lead to anemia-like symptoms (e.g., fatigue, dizziness and chest pain), hepatic encephalopathy, hepatorenal syndrome, shock and death.
Successful treatment of GI bleeding typically includes addressing the cause of the bleeding and/or haemostasis. For example, peptic ulcers may be associated with an infection of Helicobacter pylori and, therefore, may require treatment of the infection to reduce the risk of re-bleeding coupled with tissue coagulation to achieve haemostasis.
Haemostasis may be achieved by invasive surgery or by various less invasive endoscopic techniques, such as laser treatment, bipolar electrocautery, heat probing, injections with sclerosing agents (e.g., epinephrine) or application of mechanical clips. While prior art endoscopic haemostasis techniques have presented some success, physicians continue to seek improved techniques for achieving haemostasis, while reducing damage to tissue adjacent to the treated tissue.
Accordingly, there is a need for an improved apparatus and system for achieving haemostasis in the GI tract.